In India, to question is to be âanti-nationalâ
You canât even make a joke, let alone question those in power.
07 Jan, 2021
To question or not to question. That is literally the question that the media, and citizens, face in India.
In a democracy, the media is expected not just to speak truth to power, but also to question those in power. In the India of 2021, the bulk of the media does neither. And yet, for the moment at least, we are still considered the largest democracy in the world.
As for citizens who do either or both, speak the truth and question, there is hell to pay. This is evident in the number of students, activists and intellectuals who have been arrested and remain incarcerated without facing a trial in the last few years.
Is Covid-19 vaccine safe and mandatory? All questions answered
Is Covid-19 vaccine safe and mandatory? All questions answered
There are a host of questions that are arising around the coronavirus vaccines that have been recently approved in India. Here are all your questions answered.
advertisement
UPDATED: January 6, 2021 19:53 IST
The Indian government is expected to start coronavirus vaccination drive in a few weeks. (Photo: India Today)
India has approved two vaccines Covishield and Covaxin
for emergency use to fight Covid-19 pandemic in the country. The mass vaccination drive is likely to begin in a couple of weeks.
Based on expert opinions recorded along the way, here s all you need to know about the Covid-19 vaccine:
Prime Minister Narendra Modi congratulated the nation and thanked the scientific and healthcare community on Sunday after the Drugs Controller General of India (DCGI) officially approved Oxford-AstraZeneca and Bharat Biotech’s Covid-19 vaccines for emergency use.
India Tests Vaccine Delivery Systems as 4-5 Cr Doses of Oxford-AstraZeneca s Jab Stockpiled Pre-rollout
FOLLOW US ON:
The Serum Institute of India, which is manufacturing the Oxford-AstraZeneca vaccine, has already stockpiled 40-50 million dosages of the Covid-19 vaccine ahead of the inoculation drive in India, the company’s CEO Adar Poonawalla said on Monday, adding that the firm will be able to produce around 300 million doses by July next year.
The emergency use authorisation for the Oxford-AstraZeneca vaccine is expected within days and four states - Punjab, Gujarat, Assam and Andhra Pradesh - on Monday began a trial run of vaccine delivery systems, checking everything from their technology platforms to the storage infrastructure that will be required to inoculate millions.